In fact, GIP infusions have been shown to be able to stimulate NEFA esterification in the AT of patients with type 2 diabetes (T2D) despite being unable to stimulate insulin secretion, which occurs in euglycemic individuals [12]. Here, GIP is linked to type 2 diabetes mellitus.